6 Recruiting Studies Using Itacitinib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Itacitinib
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Itacitinib for the Prevention of Graft Versus Host Disease
📍 M D Anderson Cancer Center — Houston, Texas
Hematologic and Lymphocytic Disorder
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Leukemia, Acute
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Itacitinib + Everolimus in Hodgkin Lymphoma
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Classical Hodgkin Lymphoma
View Study & Checklist ➔ RECRUITING Phase1 / Phase2 💊 Investigational Drug / Biologic
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
📍 Moffitt Cancer Center — Tampa, Florida
MDS/MPN
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
📍 Moffitt Cancer Center — Tampa, Florida
Diffuse Large B Cell Lymphoma
View Study & Checklist ➔